Potential transmission chains of variant B.1.1.7 and co-mutations of SARS-CoV-2

被引:0
|
作者
Jingsong Zhang
Yang Zhang
Jun-Yan Kang
Shuiye Chen
Yongqun He
Benhao Han
Mo-Fang Liu
Lina Lu
Li Li
Zhigang Yi
Luonan Chen
机构
[1] Chinese Academy of Sciences,State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science
[2] Fudan University,Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College
[3] Chinese Academy of Sciences,State Key Laboratory of Molecular Biology, Shanghai Key Laboratory of Molecular Andrology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science
[4] University of Chinese Academy of Sciences,Department of Computational Medicine and Bioinformatics
[5] University of Michigan Medical School,Department of Genetics
[6] Harvard Medical School,Shanghai Public Health Clinical Center
[7] Fudan University,School of Life Science and Technology
[8] ShanghaiTech University,Key Laboratory of Systems Health Science of Zhejiang Province, Hangzhou Institute for Advanced Study
[9] University of Chinese Academy of Sciences,undefined
[10] Pazhou Lab,undefined
来源
Cell Discovery | / 7卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The presence of SARS-CoV-2 mutants, including the emerging variant B.1.1.7, has raised great concerns in terms of pathogenesis, transmission, and immune escape. Characterizing SARS-CoV-2 mutations, evolution, and effects on infectivity and pathogenicity is crucial to the design of antibody therapies and surveillance strategies. Here, we analyzed 454,443 SARS-CoV-2 spike genes/proteins and 14,427 whole-genome sequences. We demonstrated that the early variant B.1.1.7 may not have evolved spontaneously in the United Kingdom or within human populations. Our extensive analyses suggested that Canidae, Mustelidae or Felidae, especially the Canidae family (for example, dog) could be a possible host of the direct progenitor of variant B.1.1.7. An alternative hypothesis is that the variant was simply yet to be sampled. Notably, the SARS-CoV-2 whole-genome represents a large number of potential co-mutations. In addition, we used an experimental SARS-CoV-2 reporter replicon system to introduce the dominant co-mutations NSP12_c14408t, 5′UTR_c241t, and NSP3_c3037t into the viral genome, and to monitor the effect of the mutations on viral replication. Our experimental results demonstrated that the co-mutations significantly attenuated the viral replication. The study provides valuable clues for discovering the transmission chains of variant B.1.1.7 and understanding the evolutionary process of SARS-CoV-2.
引用
收藏
相关论文
共 50 条
  • [41] Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
    Volz, Erik
    Mishra, Swapnil
    Chand, Meera
    Barrett, Jeffrey C.
    Johnson, Robert
    Geidelberg, Lily
    Hinsley, Wes R.
    Laydon, Daniel J.
    Dabrera, Gavin
    Toole, Aine O.
    Amato, Robert
    Ragonnet-Cronin, Manon
    Harrison, Ian
    Jackson, Ben
    Ariani, Cristina, V
    Boyd, Olivia
    Loman, Nicholas J.
    McCrone, John T.
    Goncalves, Sonia
    Jorgensen, David
    Myers, Richard
    Hill, Verity
    Jackson, David K.
    Gaythorpe, Katy
    Groves, Natalie
    Sillitoe, John
    Kwiatkowski, Dominic P.
    Flaxman, Seth
    Ratmann, Oliver
    Bhatt, Samir
    Hopkins, Susan
    Gandy, Axel
    Rambaut, Andrew
    Ferguson, Neil M.
    NATURE, 2021, 593 (7858) : 266 - +
  • [42] Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
    Erik Volz
    Swapnil Mishra
    Meera Chand
    Jeffrey C. Barrett
    Robert Johnson
    Lily Geidelberg
    Wes R. Hinsley
    Daniel J. Laydon
    Gavin Dabrera
    Áine O’Toole
    Robert Amato
    Manon Ragonnet-Cronin
    Ian Harrison
    Ben Jackson
    Cristina V. Ariani
    Olivia Boyd
    Nicholas J. Loman
    John T. McCrone
    Sónia Gonçalves
    David Jorgensen
    Richard Myers
    Verity Hill
    David K. Jackson
    Katy Gaythorpe
    Natalie Groves
    John Sillitoe
    Dominic P. Kwiatkowski
    Seth Flaxman
    Oliver Ratmann
    Samir Bhatt
    Susan Hopkins
    Axel Gandy
    Andrew Rambaut
    Neil M. Ferguson
    Nature, 2021, 593 : 266 - 269
  • [43] Epidemic Spread of SARS-CoV-2 Lineage B.1.1.7 in Brazil
    Moreira, Filipe R. R.
    Bonfim, Diego M.
    Zauli, Danielle A. G.
    Silva, Joice P.
    Lima, Aline B.
    Malta, Frederico S. V.
    Ferreira, Alessandro C. S.
    Pardini, Victor C.
    Magalhaes, Wagner C. S.
    Queiroz, Daniel C.
    Souza, Rafael M.
    Geddes, Victor E. V.
    Costa, Walyson C.
    Moreira, Rennan G.
    Faria, Nuno R.
    Voloch, Carolina M.
    Souza, Renan P.
    Aguiar, Renato S.
    VIRUSES-BASEL, 2021, 13 (06):
  • [44] Emerging SARS-CoV-2 variant B.1.1.7 reduces neutralisation activity of antibodies against wild-type SARS-CoV-2
    Mueller, Katharina
    Girl, Philipp
    Giebl, Andreas
    von Buttlar, Heiner
    Dobler, Gerhard
    Bugert, Joachim J.
    Gruetzner, Stefanie
    Wolfel, Roman
    JOURNAL OF CLINICAL VIROLOGY, 2021, 142
  • [45] Genome Sequence of a SARS-CoV-2 Strain from Bangladesh That Is Nearly Identical to United Kingdom SARS-CoV-2 Variant B.1.1.7
    Hossain, Mohammad Enayet
    Rahman, M. Mahfuzur
    Alam, M. Shaheen
    Karim, Yeasir
    Hoque, Ananya Ferdous
    Rahman, Sezanur
    Rahman, Mohammed Ziaur
    Rahman, Mustafizur
    MICROBIOLOGY RESOURCE ANNOUNCEMENTS, 2021, 10 (08):
  • [46] Probable vertical transmission of Alpha variant of concern (B.1.1.7) with evidence of SARS-CoV-2 infection in the syncytiotrophoblast, a case report
    Bullock, Hannah A.
    Fuchs, Erika
    Martines, Roosecelis B.
    Lush, Mamie
    Bollweg, Brigid
    Rutan, Alyssa
    Nelson, Amy
    Brisso, Mark
    Owusu-Ansah, Albert
    Sitzman, Craig
    Ketterl, Laurie
    Timmons, Tim
    Lopez, Patricia
    Mitchell, Elizabeth
    McCutchen, Emily
    Figliomeni, Jonathan
    Iwen, Peter
    Uyeki, Timothy M.
    Reagan-Steiner, Sarah
    Donahue, Matthew
    FRONTIERS IN MEDICINE, 2023, 9
  • [47] Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study
    Graham, Mark S.
    Sudre, Carole H.
    May, Anna
    Antonelli, Michela
    Murray, Benjamin
    Varsaysky, Thomas
    Klaser, Kerstin
    Canas, Liane S.
    Molteni, Erika
    Modat, Marc
    Drew, David A.
    Nguyen, Long H.
    Polidori, Lorenzo
    Selvachandran, Somesh
    Hu, Christina
    Capdevila, Joan
    Hammers, Alexander
    Chan, Andrew T.
    Wolf, Jonathan
    Spector, Tins D.
    Steves, Claire J.
    Ourselin, Sebastien
    LANCET PUBLIC HEALTH, 2021, 6 (05): : E335 - E345
  • [48] Emergence of SARS CoV-2 Variant B.1.1.7 in a Pandemic Hospital
    Bilgin, Melek
    Taskin, Mehmet Hakan
    Ozgen, Emre
    Yavuz, Demet
    FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2022, 27 (04): : 578 - 586
  • [49] SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
    Shen, Xiaoying
    Tang, Haili
    McDanal, Charlene
    Wagh, Kshitij
    Fischer, William
    Theiler, James
    Yoon, Hyejin
    Li, Dapeng
    Haynes, Barton F.
    Sanders, Kevin O.
    Gnanakaran, Sandrasegaram
    Hengartner, Nick
    Pajon, Rolando
    Smith, Gale
    Glenn, Gregory M.
    Korber, Bette
    Montefiori, David C.
    CELL HOST & MICROBE, 2021, 29 (04) : 529 - +
  • [50] Detection and abundance of SARS-CoV-2 in wastewater in Liechtenstein, and the estimation of prevalence and impact of the B.1.1.7 variant
    Markt, R.
    Endler, L.
    Amman, F.
    Schedl, A.
    Penz, T.
    Buchel-Marxer, M.
    Grunbacher, D.
    Mayr, M.
    Peer, E.
    Pedrazzini, M.
    Rauch, W.
    Wagner, A. O.
    Allerberger, F.
    Bergthaler, A.
    Insam, H.
    JOURNAL OF WATER AND HEALTH, 2022, 20 (01) : 114 - 125